Stenhouse Mark

SEC source: 0001193125-26-234568 · ownership.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,122

F1 · shares: The Restricted Stock Units ("RSUs") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

SEC source: 0000950170-25-082448 · ownership.xml · derivative · entry 2

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2035-06-02

F2 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

SEC source: 0000950170-25-082448 · ownership.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

SEC source: 0000950170-24-064813 · ownership.xml · derivative · entry 2

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2034-05-22

F2 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

SEC source: 0000950170-24-064813 · ownership.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,500

F1 · shares: The Restricted Stock Units ("RSUs") were granted on May 23, 2024, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

SEC source: 0000899243-23-015761 · doc4.xml · derivative · entry 7

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,085 shares

Expires 2032-12-08

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · derivative.exercise_date: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0000899243-23-015761 · doc4.xml · derivative · entry 6

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 86,582 shares

Expires 2032-05-19

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · derivative.exercise_date: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0000899243-23-015761 · doc4.xml · derivative · entry 5

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 70,371 shares

Expires 2031-11-13

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · derivative.exercise_date: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0000899243-23-015761 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 240,000 shares

Expires 2031-02-08

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · derivative.exercise_date: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0000899243-23-015761 · doc4.xml · derivative · entry 3

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2028-05-22

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · derivative.exercise_date: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0000899243-23-015761 · doc4.xml · nonDerivative · entry 2

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Stenhouse Family Fund

Disclosed balance after: 0

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

F4 · ownership.nature: The Reporting Person is a Donor of the Stenhouse Family Fund.

SEC source: 0000899243-23-015761 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Includes 9,811 restricted stock units.

F2 · price: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3 · price: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

SEC source: 0001209191-23-034013 · doc4.xml · nonDerivative · entry 2

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Stenhouse Family Fund

Disclosed balance after: 14,000

F1 · kind: Transfer of shares from the Reporting Person to the Stenhouse Family Fund, a Charitable Gift Fund (the "Stenhouse Family Fund").

F3 · ownership.nature: The Reporting Person is a Donor of the Stenhouse Family Fund.

SEC source: 0001209191-23-034013 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,708

F1 · kind: Transfer of shares from the Reporting Person to the Stenhouse Family Fund, a Charitable Gift Fund (the "Stenhouse Family Fund").

F2 · balance_after: Includes a total of 266 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.

SEC source: 0001209191-23-033022 · doc4.xml · derivative · entry 2

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-05-24

F2 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing in service on the Board through such vesting date.

SEC source: 0001209191-23-033022 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

F1 · shares: The Restricted Stock Units ("RSUs") were granted on May 25, 2023, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

SEC source: 0001209191-22-061090 · doc4.xml · derivative · entry 2

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,085

Underlying: Common Stock · 34,085 shares

Expires 2032-12-08

F3 · derivative.exercise_date: 25% of the shares subject to the option will vest on December 9, 2023, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Report Person's continued service with the Issuer through each vest date.

SEC source: 0001209191-22-061090 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,442

F1 · kind: Award of restricted stock units ("RSUs") granted under the Issuer's 2021 Incentive Award Plan. Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting. The award will vest and settle with respect to twenty-five percent (25%) of the total number of RSUs on December 9, 2023, 2024, 2025 and 2026, subject to the Reporting Person's continued service with the Issuer through each vest date.

F2 · balance_after: Includes a total of 2,631 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.

SEC source: 0001209191-22-032588 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-05-24

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

SEC source: 0001209191-22-031169 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,582

Underlying: Common Stock · 86,582 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the third anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

SEC source: 0001209191-21-064936 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,371

Underlying: Common Stock · 70,371 shares

Expires 2031-11-13

F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.

SEC source: 0001209191-21-035474 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2031-05-20

F1 · derivative.exercise_date: The option was granted pursuant to the Registrant's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Registrant's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

SEC source: 0001209191-21-021219 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

SEC source: 0001209191-20-023603 · doc4.xml · nonDerivative · entry 2

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,571

F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on April 2, 2020.

F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 29,926 shares, Mr. Stenhouse also holds, in the aggregate, an additional 71,143 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

SEC source: 0001209191-20-023603 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5 · derivative.exercise_date: Represents a restricted stock unit award granted on April 2, 2018 that partially vested on April 2, 2020. The restricted stock units vest in three equal annual installments beginning on April 2, 2019.

F5 · derivative.expiration_date: Represents a restricted stock unit award granted on April 2, 2018 that partially vested on April 2, 2020. The restricted stock units vest in three equal annual installments beginning on April 2, 2019.

SEC source: 0001209191-20-023603 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award.

SEC source: 0001209191-20-020283 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-03-16

F1 · derivative.exercise_date: The option will vest with respect to one-third of the shares of common stock on March 17, 2021, and will vest with respect to the remaining shares in equal monthly installments over the following two years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.

SEC source: 0001209191-20-013916 · doc4.xml · nonDerivative · entry 2

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,519

F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2020.

F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 16,874 shares, Mr. Stenhouse also holds, in the aggregate, an additional 96,143 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

SEC source: 0001209191-20-013916 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,789

Underlying: Common Stock · 3,262 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2020. The restricted stock units vest in four equal annual installments beginning on February 26, 2020.

F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2020. The restricted stock units vest in four equal annual installments beginning on February 26, 2020.

SEC source: 0001209191-20-013916 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award.

SEC source: 0001209191-20-010183 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,445

Underlying: Common Stock · 11,445 shares

Expires 2030-02-14

F4 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001209191-20-010183 · doc4.xml · derivative · entry 3

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,123

Underlying: Common Stock · 14,123 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001209191-19-023646 · doc4.xml · nonDerivative · entry 2

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,308

F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on April 2, 2019.

F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 14,471 shares, Mr. Stenhouse also holds, in the aggregate, an additional 73,837 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

SEC source: 0001209191-19-023646 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5 · derivative.exercise_date: Represents a restricted stock unit award granted on April 2, 2018 that partially vested on April 2, 2019. The restricted stock units vest in three equal annual installments beginning on April 2, 2019.

F5 · derivative.expiration_date: Represents a restricted stock unit award granted on April 2, 2018 that partially vested on April 2, 2019. The restricted stock units vest in three equal annual installments beginning on April 2, 2019.

SEC source: 0001209191-19-023646 · doc4.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award.

SEC source: 0001209191-19-014811 · doc4.xml · derivative · entry 4

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,051

Underlying: Common Stock · 13,051 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F4 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001209191-19-014811 · doc4.xml · derivative · entry 3

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,786

Underlying: Common Stock · 10,786 shares

Expires 2029-02-26

F2 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001209191-19-008602 · doc5.xml · nonDerivative · entry 1

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan.

SEC source: 0001209191-18-023111 · doc4.xml · derivative · entry 1

Stenhouse Mark · CIK 0001734751 · President, Cologuard

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date.

F2 · derivative.expiration_date: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date.